nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—breast cancer	0.246	0.674	CbGaD
Atazanavir—CYP3A4—breast cancer	0.0649	0.178	CbGaD
Atazanavir—ABCB1—breast cancer	0.0541	0.148	CbGaD
Atazanavir—ABCC1—Idarubicin—breast cancer	0.0514	0.115	CbGbCtD
Atazanavir—SLCO1B3—Paclitaxel—breast cancer	0.0255	0.0572	CbGbCtD
Atazanavir—ABCC1—Mitoxantrone—breast cancer	0.0221	0.0496	CbGbCtD
Atazanavir—SLCO1B3—Docetaxel—breast cancer	0.0184	0.0414	CbGbCtD
Atazanavir—ABCC1—Epirubicin—breast cancer	0.0179	0.0401	CbGbCtD
Atazanavir—ABCC1—Paclitaxel—breast cancer	0.0176	0.0395	CbGbCtD
Atazanavir—ABCC1—Irinotecan—breast cancer	0.0174	0.039	CbGbCtD
Atazanavir—CYP2C9—Anastrozole—breast cancer	0.0169	0.0378	CbGbCtD
Atazanavir—ABCC1—Vinblastine—breast cancer	0.0155	0.0347	CbGbCtD
Atazanavir—ABCB1—Toremifene—breast cancer	0.015	0.0336	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—breast cancer	0.0133	0.0299	CbGbCtD
Atazanavir—CYP3A4—Exemestane—breast cancer	0.0129	0.029	CbGbCtD
Atazanavir—CYP2C9—Idarubicin—breast cancer	0.0128	0.0287	CbGbCtD
Atazanavir—ABCC1—Docetaxel—breast cancer	0.0128	0.0286	CbGbCtD
Atazanavir—CYP3A4—Letrozole—breast cancer	0.011	0.0247	CbGbCtD
Atazanavir—ABCB1—Lapatinib—breast cancer	0.0109	0.0245	CbGbCtD
Atazanavir—CYP3A4—Anastrozole—breast cancer	0.00981	0.022	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—breast cancer	0.00951	0.0213	CbGbCtD
Atazanavir—ABCC1—Methotrexate—breast cancer	0.00921	0.0206	CbGbCtD
Atazanavir—CYP3A4—Toremifene—breast cancer	0.00897	0.0201	CbGbCtD
Atazanavir—CYP3A4—Fulvestrant—breast cancer	0.00834	0.0187	CbGbCtD
Atazanavir—CYP3A4—Thiotepa—breast cancer	0.00743	0.0167	CbGbCtD
Atazanavir—CYP2C9—Capecitabine—breast cancer	0.007	0.0157	CbGbCtD
Atazanavir—CYP3A4—Ixabepilone—breast cancer	0.0068	0.0152	CbGbCtD
Atazanavir—CYP3A4—Lapatinib—breast cancer	0.00654	0.0147	CbGbCtD
Atazanavir—ABCB1—Vinorelbine—breast cancer	0.00606	0.0136	CbGbCtD
Atazanavir—CYP2C9—Tamoxifen—breast cancer	0.00563	0.0126	CbGbCtD
Atazanavir—ABCB1—Tamoxifen—breast cancer	0.00547	0.0123	CbGbCtD
Atazanavir—ABCB1—Mitoxantrone—breast cancer	0.00533	0.012	CbGbCtD
Atazanavir—CYP3A4—Raloxifene—breast cancer	0.00496	0.0111	CbGbCtD
Atazanavir—ABCB1—Gemcitabine—breast cancer	0.00471	0.0106	CbGbCtD
Atazanavir—CYP2C9—Paclitaxel—breast cancer	0.00439	0.00983	CbGbCtD
Atazanavir—ABCB1—Paclitaxel—breast cancer	0.00426	0.00954	CbGbCtD
Atazanavir—ABCB1—Irinotecan—breast cancer	0.0042	0.00941	CbGbCtD
Atazanavir—CYP2C9—Fluorouracil—breast cancer	0.00415	0.00931	CbGbCtD
Atazanavir—ABCB1—Vinblastine—breast cancer	0.00373	0.00837	CbGbCtD
Atazanavir—CYP3A4—Vinorelbine—breast cancer	0.00363	0.00814	CbGbCtD
Atazanavir—CYP3A4—Tamoxifen—breast cancer	0.00328	0.00735	CbGbCtD
Atazanavir—CYP3A4—Mitoxantrone—breast cancer	0.00319	0.00716	CbGbCtD
Atazanavir—ABCB1—Docetaxel—breast cancer	0.00308	0.0069	CbGbCtD
Atazanavir—CYP3A4—Paclitaxel—breast cancer	0.00255	0.00572	CbGbCtD
Atazanavir—CYP3A4—Irinotecan—breast cancer	0.00252	0.00564	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—breast cancer	0.00229	0.00514	CbGbCtD
Atazanavir—CYP3A4—Vinblastine—breast cancer	0.00224	0.00501	CbGbCtD
Atazanavir—ABCB1—Methotrexate—breast cancer	0.00222	0.00498	CbGbCtD
Atazanavir—CYP3A4—Docetaxel—breast cancer	0.00184	0.00413	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—breast cancer	0.00137	0.00308	CbGbCtD
Atazanavir—Ritonavir—SLCO1B1—breast cancer	0.000595	0.165	CrCbGaD
Atazanavir—Ritonavir—ABCC1—breast cancer	0.000491	0.137	CrCbGaD
Atazanavir—Saquinavir—SLCO1B1—breast cancer	0.000451	0.125	CrCbGaD
Atazanavir—Saquinavir—ABCC1—breast cancer	0.000372	0.104	CrCbGaD
Atazanavir—Ritonavir—ABCG2—breast cancer	0.000259	0.072	CrCbGaD
Atazanavir—Saquinavir—ABCG2—breast cancer	0.000196	0.0546	CrCbGaD
Atazanavir—Lopinavir—CYP2D6—breast cancer	0.00018	0.0499	CrCbGaD
Atazanavir—Lopinavir—CYP3A4—breast cancer	0.000154	0.0428	CrCbGaD
Atazanavir—Ritonavir—CYP2D6—breast cancer	0.000151	0.042	CrCbGaD
Atazanavir—Ritonavir—CYP3A4—breast cancer	0.000129	0.036	CrCbGaD
Atazanavir—Lopinavir—ABCB1—breast cancer	0.000128	0.0357	CrCbGaD
Atazanavir—Saquinavir—CYP2D6—breast cancer	0.000114	0.0318	CrCbGaD
Atazanavir—Ritonavir—ABCB1—breast cancer	0.000108	0.03	CrCbGaD
Atazanavir—Saquinavir—CYP3A4—breast cancer	9.81e-05	0.0273	CrCbGaD
Atazanavir—Saquinavir—ALB—breast cancer	8.56e-05	0.0238	CrCbGaD
Atazanavir—Saquinavir—ABCB1—breast cancer	8.17e-05	0.0227	CrCbGaD
Atazanavir—Musculoskeletal discomfort—Docetaxel—breast cancer	2.52e-05	0.000179	CcSEcCtD
Atazanavir—Headache—Mitoxantrone—breast cancer	2.5e-05	0.000178	CcSEcCtD
Atazanavir—Headache—Irinotecan—breast cancer	2.5e-05	0.000178	CcSEcCtD
Atazanavir—Insomnia—Docetaxel—breast cancer	2.5e-05	0.000177	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—breast cancer	2.48e-05	0.000176	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—breast cancer	2.48e-05	0.000176	CcSEcCtD
Atazanavir—Vomiting—Gemcitabine—breast cancer	2.48e-05	0.000176	CcSEcCtD
Atazanavir—Dyspnoea—Docetaxel—breast cancer	2.46e-05	0.000175	CcSEcCtD
Atazanavir—Somnolence—Docetaxel—breast cancer	2.46e-05	0.000174	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—breast cancer	2.46e-05	0.000174	CcSEcCtD
Atazanavir—Rash—Gemcitabine—breast cancer	2.46e-05	0.000174	CcSEcCtD
Atazanavir—Dermatitis—Gemcitabine—breast cancer	2.45e-05	0.000174	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—breast cancer	2.45e-05	0.000174	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—breast cancer	2.45e-05	0.000174	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—breast cancer	2.44e-05	0.000173	CcSEcCtD
Atazanavir—Headache—Gemcitabine—breast cancer	2.44e-05	0.000173	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Capecitabine—breast cancer	2.44e-05	0.000173	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—breast cancer	2.44e-05	0.000173	CcSEcCtD
Atazanavir—Vomiting—Fluorouracil—breast cancer	2.43e-05	0.000173	CcSEcCtD
Atazanavir—Dyspepsia—Docetaxel—breast cancer	2.43e-05	0.000173	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—breast cancer	2.43e-05	0.000172	CcSEcCtD
Atazanavir—Insomnia—Capecitabine—breast cancer	2.42e-05	0.000172	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—breast cancer	2.42e-05	0.000171	CcSEcCtD
Atazanavir—Rash—Fluorouracil—breast cancer	2.41e-05	0.000171	CcSEcCtD
Atazanavir—Dermatitis—Fluorouracil—breast cancer	2.41e-05	0.000171	CcSEcCtD
Atazanavir—Decreased appetite—Docetaxel—breast cancer	2.4e-05	0.000171	CcSEcCtD
Atazanavir—Hypersensitivity—Paclitaxel—breast cancer	2.4e-05	0.000171	CcSEcCtD
Atazanavir—Headache—Fluorouracil—breast cancer	2.4e-05	0.00017	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—breast cancer	2.4e-05	0.00017	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—breast cancer	2.39e-05	0.00017	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—breast cancer	2.39e-05	0.00017	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Docetaxel—breast cancer	2.39e-05	0.000169	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—breast cancer	2.39e-05	0.000169	CcSEcCtD
Atazanavir—Dyspnoea—Capecitabine—breast cancer	2.39e-05	0.000169	CcSEcCtD
Atazanavir—Fatigue—Docetaxel—breast cancer	2.38e-05	0.000169	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—breast cancer	2.38e-05	0.000169	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—breast cancer	2.38e-05	0.000169	CcSEcCtD
Atazanavir—Nausea—Mitoxantrone—breast cancer	2.37e-05	0.000169	CcSEcCtD
Atazanavir—Nausea—Irinotecan—breast cancer	2.37e-05	0.000169	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—breast cancer	2.37e-05	0.000168	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—breast cancer	2.36e-05	0.000168	CcSEcCtD
Atazanavir—Pain—Docetaxel—breast cancer	2.36e-05	0.000168	CcSEcCtD
Atazanavir—Constipation—Docetaxel—breast cancer	2.36e-05	0.000168	CcSEcCtD
Atazanavir—Back pain—Methotrexate—breast cancer	2.36e-05	0.000168	CcSEcCtD
Atazanavir—Dyspepsia—Capecitabine—breast cancer	2.36e-05	0.000167	CcSEcCtD
Atazanavir—Asthenia—Paclitaxel—breast cancer	2.34e-05	0.000166	CcSEcCtD
Atazanavir—Decreased appetite—Capecitabine—breast cancer	2.33e-05	0.000165	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—breast cancer	2.32e-05	0.000165	CcSEcCtD
Atazanavir—Nausea—Gemcitabine—breast cancer	2.31e-05	0.000164	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Capecitabine—breast cancer	2.31e-05	0.000164	CcSEcCtD
Atazanavir—Fatigue—Capecitabine—breast cancer	2.31e-05	0.000164	CcSEcCtD
Atazanavir—Pruritus—Paclitaxel—breast cancer	2.31e-05	0.000164	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—breast cancer	2.3e-05	0.000163	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—breast cancer	2.3e-05	0.000163	CcSEcCtD
Atazanavir—Pain—Capecitabine—breast cancer	2.29e-05	0.000162	CcSEcCtD
Atazanavir—Constipation—Capecitabine—breast cancer	2.29e-05	0.000162	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—breast cancer	2.28e-05	0.000162	CcSEcCtD
Atazanavir—Feeling abnormal—Docetaxel—breast cancer	2.28e-05	0.000162	CcSEcCtD
Atazanavir—Nausea—Fluorouracil—breast cancer	2.27e-05	0.000161	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—breast cancer	2.27e-05	0.000161	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—breast cancer	2.26e-05	0.000161	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—breast cancer	2.26e-05	0.000161	CcSEcCtD
Atazanavir—Gastrointestinal pain—Docetaxel—breast cancer	2.26e-05	0.00016	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—breast cancer	2.25e-05	0.00016	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—breast cancer	2.25e-05	0.00016	CcSEcCtD
Atazanavir—Tension—Epirubicin—breast cancer	2.24e-05	0.000159	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—breast cancer	2.24e-05	0.000159	CcSEcCtD
Atazanavir—Diarrhoea—Paclitaxel—breast cancer	2.23e-05	0.000158	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—breast cancer	2.22e-05	0.000157	CcSEcCtD
Atazanavir—Back pain—Epirubicin—breast cancer	2.21e-05	0.000157	CcSEcCtD
Atazanavir—Feeling abnormal—Capecitabine—breast cancer	2.21e-05	0.000157	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—breast cancer	2.2e-05	0.000156	CcSEcCtD
Atazanavir—Malaise—Methotrexate—breast cancer	2.2e-05	0.000156	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—breast cancer	2.19e-05	0.000156	CcSEcCtD
Atazanavir—Gastrointestinal pain—Capecitabine—breast cancer	2.19e-05	0.000155	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—breast cancer	2.19e-05	0.000155	CcSEcCtD
Atazanavir—Body temperature increased—Docetaxel—breast cancer	2.18e-05	0.000155	CcSEcCtD
Atazanavir—Abdominal pain—Docetaxel—breast cancer	2.18e-05	0.000155	CcSEcCtD
Atazanavir—Dizziness—Paclitaxel—breast cancer	2.16e-05	0.000153	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—breast cancer	2.15e-05	0.000152	CcSEcCtD
Atazanavir—Cough—Methotrexate—breast cancer	2.13e-05	0.000151	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—breast cancer	2.13e-05	0.000151	CcSEcCtD
Atazanavir—Urticaria—Capecitabine—breast cancer	2.13e-05	0.000151	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—breast cancer	2.12e-05	0.00015	CcSEcCtD
Atazanavir—Abdominal pain—Capecitabine—breast cancer	2.12e-05	0.00015	CcSEcCtD
Atazanavir—Body temperature increased—Capecitabine—breast cancer	2.12e-05	0.00015	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—breast cancer	2.11e-05	0.00015	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—breast cancer	2.11e-05	0.00015	CcSEcCtD
Atazanavir—Agitation—Epirubicin—breast cancer	2.1e-05	0.000149	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—breast cancer	2.08e-05	0.000148	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—breast cancer	2.08e-05	0.000148	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—breast cancer	2.08e-05	0.000148	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—breast cancer	2.08e-05	0.000148	CcSEcCtD
Atazanavir—Tension—Doxorubicin—breast cancer	2.07e-05	0.000147	CcSEcCtD
Atazanavir—Vomiting—Paclitaxel—breast cancer	2.07e-05	0.000147	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—breast cancer	2.07e-05	0.000147	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.06e-05	0.000146	CcSEcCtD
Atazanavir—Malaise—Epirubicin—breast cancer	2.06e-05	0.000146	CcSEcCtD
Atazanavir—Rash—Paclitaxel—breast cancer	2.06e-05	0.000146	CcSEcCtD
Atazanavir—Dermatitis—Paclitaxel—breast cancer	2.05e-05	0.000146	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—breast cancer	2.05e-05	0.000146	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—breast cancer	2.05e-05	0.000146	CcSEcCtD
Atazanavir—Syncope—Epirubicin—breast cancer	2.05e-05	0.000145	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—breast cancer	2.04e-05	0.000145	CcSEcCtD
Atazanavir—Headache—Paclitaxel—breast cancer	2.04e-05	0.000145	CcSEcCtD
Atazanavir—Hypersensitivity—Docetaxel—breast cancer	2.04e-05	0.000145	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—breast cancer	2.02e-05	0.000143	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—breast cancer	2.01e-05	0.000143	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—breast cancer	2.01e-05	0.000143	CcSEcCtD
Atazanavir—Cough—Epirubicin—breast cancer	1.99e-05	0.000141	CcSEcCtD
Atazanavir—Asthenia—Docetaxel—breast cancer	1.98e-05	0.000141	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—breast cancer	1.98e-05	0.00014	CcSEcCtD
Atazanavir—Infection—Methotrexate—breast cancer	1.98e-05	0.00014	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—breast cancer	1.97e-05	0.00014	CcSEcCtD
Atazanavir—Hypersensitivity—Capecitabine—breast cancer	1.97e-05	0.00014	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—breast cancer	1.96e-05	0.000139	CcSEcCtD
Atazanavir—Pruritus—Docetaxel—breast cancer	1.96e-05	0.000139	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—breast cancer	1.95e-05	0.000139	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—breast cancer	1.94e-05	0.000138	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—breast cancer	1.94e-05	0.000138	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—breast cancer	1.94e-05	0.000138	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—breast cancer	1.94e-05	0.000138	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—breast cancer	1.94e-05	0.000138	CcSEcCtD
Atazanavir—Nausea—Paclitaxel—breast cancer	1.94e-05	0.000137	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—breast cancer	1.93e-05	0.000137	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.93e-05	0.000137	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—breast cancer	1.93e-05	0.000137	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—breast cancer	1.92e-05	0.000136	CcSEcCtD
Atazanavir—Asthenia—Capecitabine—breast cancer	1.92e-05	0.000136	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—breast cancer	1.91e-05	0.000135	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—breast cancer	1.9e-05	0.000135	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—breast cancer	1.9e-05	0.000135	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—breast cancer	1.9e-05	0.000135	CcSEcCtD
Atazanavir—Pruritus—Capecitabine—breast cancer	1.89e-05	0.000134	CcSEcCtD
Atazanavir—Diarrhoea—Docetaxel—breast cancer	1.89e-05	0.000134	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—breast cancer	1.88e-05	0.000133	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—breast cancer	1.87e-05	0.000133	CcSEcCtD
Atazanavir—Oedema—Epirubicin—breast cancer	1.86e-05	0.000132	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—breast cancer	1.86e-05	0.000132	CcSEcCtD
Atazanavir—Infection—Epirubicin—breast cancer	1.85e-05	0.000131	CcSEcCtD
Atazanavir—Cough—Doxorubicin—breast cancer	1.84e-05	0.000131	CcSEcCtD
Atazanavir—Shock—Epirubicin—breast cancer	1.83e-05	0.00013	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—breast cancer	1.83e-05	0.00013	CcSEcCtD
Atazanavir—Diarrhoea—Capecitabine—breast cancer	1.83e-05	0.00013	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—breast cancer	1.83e-05	0.00013	CcSEcCtD
Atazanavir—Dizziness—Docetaxel—breast cancer	1.83e-05	0.00013	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—breast cancer	1.82e-05	0.00013	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—breast cancer	1.81e-05	0.000129	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—breast cancer	1.81e-05	0.000129	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—breast cancer	1.8e-05	0.000128	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—breast cancer	1.8e-05	0.000128	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—breast cancer	1.8e-05	0.000128	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—breast cancer	1.8e-05	0.000128	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—breast cancer	1.8e-05	0.000128	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—breast cancer	1.79e-05	0.000127	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.79e-05	0.000127	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—breast cancer	1.78e-05	0.000126	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—breast cancer	1.78e-05	0.000126	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—breast cancer	1.78e-05	0.000126	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—breast cancer	1.77e-05	0.000126	CcSEcCtD
Atazanavir—Dizziness—Capecitabine—breast cancer	1.77e-05	0.000126	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—breast cancer	1.76e-05	0.000125	CcSEcCtD
Atazanavir—Vomiting—Docetaxel—breast cancer	1.76e-05	0.000125	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—breast cancer	1.75e-05	0.000124	CcSEcCtD
Atazanavir—Rash—Docetaxel—breast cancer	1.74e-05	0.000124	CcSEcCtD
Atazanavir—Dermatitis—Docetaxel—breast cancer	1.74e-05	0.000124	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—breast cancer	1.74e-05	0.000123	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—breast cancer	1.73e-05	0.000123	CcSEcCtD
Atazanavir—Headache—Docetaxel—breast cancer	1.73e-05	0.000123	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—breast cancer	1.72e-05	0.000122	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—breast cancer	1.72e-05	0.000122	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—breast cancer	1.72e-05	0.000122	CcSEcCtD
Atazanavir—Infection—Doxorubicin—breast cancer	1.71e-05	0.000122	CcSEcCtD
Atazanavir—Pain—Methotrexate—breast cancer	1.7e-05	0.000121	CcSEcCtD
Atazanavir—Vomiting—Capecitabine—breast cancer	1.7e-05	0.000121	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—breast cancer	1.7e-05	0.000121	CcSEcCtD
Atazanavir—Shock—Doxorubicin—breast cancer	1.7e-05	0.00012	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—breast cancer	1.69e-05	0.00012	CcSEcCtD
Atazanavir—Rash—Capecitabine—breast cancer	1.69e-05	0.00012	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—breast cancer	1.69e-05	0.00012	CcSEcCtD
Atazanavir—Dermatitis—Capecitabine—breast cancer	1.69e-05	0.00012	CcSEcCtD
Atazanavir—Headache—Capecitabine—breast cancer	1.68e-05	0.000119	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—breast cancer	1.68e-05	0.000119	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—breast cancer	1.67e-05	0.000118	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—breast cancer	1.66e-05	0.000118	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—breast cancer	1.66e-05	0.000118	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—breast cancer	1.64e-05	0.000117	CcSEcCtD
Atazanavir—Nausea—Docetaxel—breast cancer	1.64e-05	0.000117	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—breast cancer	1.64e-05	0.000117	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—breast cancer	1.64e-05	0.000116	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—breast cancer	1.63e-05	0.000116	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—breast cancer	1.62e-05	0.000115	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—breast cancer	1.61e-05	0.000114	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—breast cancer	1.61e-05	0.000114	CcSEcCtD
Atazanavir—Constipation—Epirubicin—breast cancer	1.59e-05	0.000113	CcSEcCtD
Atazanavir—Pain—Epirubicin—breast cancer	1.59e-05	0.000113	CcSEcCtD
Atazanavir—Nausea—Capecitabine—breast cancer	1.59e-05	0.000113	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—breast cancer	1.58e-05	0.000112	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—breast cancer	1.57e-05	0.000112	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—breast cancer	1.57e-05	0.000112	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.57e-05	0.000112	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—breast cancer	1.56e-05	0.000111	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—breast cancer	1.54e-05	0.000109	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—breast cancer	1.54e-05	0.000109	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—breast cancer	1.53e-05	0.000109	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—breast cancer	1.52e-05	0.000108	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—breast cancer	1.52e-05	0.000108	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—breast cancer	1.5e-05	0.000106	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—breast cancer	1.49e-05	0.000106	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—breast cancer	1.49e-05	0.000106	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—breast cancer	1.48e-05	0.000105	CcSEcCtD
Atazanavir—Pain—Doxorubicin—breast cancer	1.48e-05	0.000105	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—breast cancer	1.48e-05	0.000105	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—breast cancer	1.47e-05	0.000105	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—breast cancer	1.47e-05	0.000105	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—breast cancer	1.47e-05	0.000104	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—breast cancer	1.43e-05	0.000101	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—breast cancer	1.42e-05	0.000101	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—breast cancer	1.41e-05	0.0001	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—breast cancer	1.41e-05	0.0001	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—breast cancer	1.37e-05	9.75e-05	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—breast cancer	1.37e-05	9.73e-05	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—breast cancer	1.36e-05	9.68e-05	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—breast cancer	1.36e-05	9.68e-05	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—breast cancer	1.36e-05	9.68e-05	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—breast cancer	1.34e-05	9.49e-05	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—breast cancer	1.32e-05	9.36e-05	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—breast cancer	1.32e-05	9.35e-05	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—breast cancer	1.28e-05	9.05e-05	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—breast cancer	1.27e-05	9.02e-05	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—breast cancer	1.27e-05	8.99e-05	CcSEcCtD
Atazanavir—Rash—Methotrexate—breast cancer	1.26e-05	8.92e-05	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—breast cancer	1.25e-05	8.91e-05	CcSEcCtD
Atazanavir—Headache—Methotrexate—breast cancer	1.25e-05	8.86e-05	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—breast cancer	1.24e-05	8.79e-05	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—breast cancer	1.23e-05	8.75e-05	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—breast cancer	1.22e-05	8.66e-05	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—breast cancer	1.19e-05	8.41e-05	CcSEcCtD
Atazanavir—Nausea—Methotrexate—breast cancer	1.18e-05	8.4e-05	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—breast cancer	1.18e-05	8.38e-05	CcSEcCtD
Atazanavir—Rash—Epirubicin—breast cancer	1.18e-05	8.34e-05	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—breast cancer	1.17e-05	8.34e-05	CcSEcCtD
Atazanavir—Headache—Epirubicin—breast cancer	1.17e-05	8.29e-05	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—breast cancer	1.14e-05	8.1e-05	CcSEcCtD
Atazanavir—Nausea—Epirubicin—breast cancer	1.11e-05	7.86e-05	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—breast cancer	1.1e-05	7.79e-05	CcSEcCtD
Atazanavir—Rash—Doxorubicin—breast cancer	1.09e-05	7.72e-05	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—breast cancer	1.09e-05	7.71e-05	CcSEcCtD
Atazanavir—Headache—Doxorubicin—breast cancer	1.08e-05	7.67e-05	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—breast cancer	1.02e-05	7.27e-05	CcSEcCtD
Atazanavir—ABCC1—Metabolism—ERCC2—breast cancer	6.25e-06	0.000142	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX4—breast cancer	6.19e-06	0.000141	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SULT1A1—breast cancer	6.19e-06	0.000141	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CD—breast cancer	6.14e-06	0.000139	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APRT—breast cancer	6.12e-06	0.000139	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS2—breast cancer	6.08e-06	0.000138	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—breast cancer	6.06e-06	0.000138	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA1—breast cancer	6.05e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—IDH1—breast cancer	6.05e-06	0.000137	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOTCH1—breast cancer	6.03e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NAT2—breast cancer	5.98e-06	0.000136	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	5.9e-06	0.000134	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KIT—breast cancer	5.89e-06	0.000134	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APC—breast cancer	5.89e-06	0.000134	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—MTHFR—breast cancer	5.87e-06	0.000133	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGF—breast cancer	5.82e-06	0.000132	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NOS3—breast cancer	5.79e-06	0.000132	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ESRRA—breast cancer	5.75e-06	0.000131	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ANGPTL4—breast cancer	5.75e-06	0.000131	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	5.7e-06	0.00013	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MED12—breast cancer	5.61e-06	0.000128	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—DPYD—breast cancer	5.61e-06	0.000128	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—breast cancer	5.54e-06	0.000126	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDOA—breast cancer	5.53e-06	0.000126	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPI—breast cancer	5.46e-06	0.000124	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HADHB—breast cancer	5.46e-06	0.000124	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CAV1—breast cancer	5.42e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	5.41e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT2—breast cancer	5.39e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOA3—breast cancer	5.36e-06	0.000122	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CB—breast cancer	5.35e-06	0.000122	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A2—breast cancer	5.33e-06	0.000121	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—breast cancer	5.3e-06	0.00012	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MED12—breast cancer	5.24e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—DPYD—breast cancer	5.24e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CPT1A—breast cancer	5.22e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG2—breast cancer	5.22e-06	0.000119	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTR—breast cancer	5.22e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH1A1—breast cancer	5.2e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDH7A1—breast cancer	5.2e-06	0.000118	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CD—breast cancer	5.18e-06	0.000118	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.18e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDOA—breast cancer	5.16e-06	0.000117	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SERPINE1—breast cancer	5.12e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HPGDS—breast cancer	5.12e-06	0.000116	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HBA1—breast cancer	5.09e-06	0.000116	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOA3—breast cancer	5.01e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UMPS—breast cancer	4.99e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PHGDH—breast cancer	4.99e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FHL2—breast cancer	4.99e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADSL—breast cancer	4.99e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NME1—breast cancer	4.99e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A2—breast cancer	4.98e-06	0.000113	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ACHE—breast cancer	4.96e-06	0.000113	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—breast cancer	4.96e-06	0.000113	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—breast cancer	4.93e-06	0.000112	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.92e-06	0.000112	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BRIP1—breast cancer	4.89e-06	0.000111	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—LDHB—breast cancer	4.89e-06	0.000111	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HPSE—breast cancer	4.89e-06	0.000111	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOS3—breast cancer	4.89e-06	0.000111	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CPT1A—breast cancer	4.88e-06	0.000111	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG2—breast cancer	4.88e-06	0.000111	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTR—breast cancer	4.88e-06	0.000111	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	4.82e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HPGDS—breast cancer	4.78e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HBA1—breast cancer	4.75e-06	0.000108	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP17A1—breast cancer	4.7e-06	0.000107	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ENO1—breast cancer	4.65e-06	0.000106	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS1—breast cancer	4.65e-06	0.000106	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MDM2—breast cancer	4.64e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA3—breast cancer	4.64e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMMR—breast cancer	4.64e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCC1—breast cancer	4.64e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—breast cancer	4.64e-06	0.000105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ACHE—breast cancer	4.64e-06	0.000105	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RAF1—breast cancer	4.62e-06	0.000105	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTEN—breast cancer	4.62e-06	0.000105	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB2—breast cancer	4.58e-06	0.000104	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2D6—breast cancer	4.56e-06	0.000104	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CB—breast cancer	4.52e-06	0.000103	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTOR—breast cancer	4.52e-06	0.000103	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD4—breast cancer	4.51e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.49e-06	0.000102	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOA2—breast cancer	4.48e-06	0.000102	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—breast cancer	4.47e-06	0.000102	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP17A1—breast cancer	4.39e-06	9.97e-05	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	4.35e-06	9.89e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS1—breast cancer	4.35e-06	9.87e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ENO1—breast cancer	4.35e-06	9.87e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—FASN—breast cancer	4.34e-06	9.87e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CD—breast cancer	4.34e-06	9.86e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.33e-06	9.84e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BCHE—breast cancer	4.32e-06	9.83e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—breast cancer	4.28e-06	9.73e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.27e-06	9.71e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC5A5—breast cancer	4.27e-06	9.71e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2D6—breast cancer	4.26e-06	9.68e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA4—breast cancer	4.24e-06	9.64e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CA9—breast cancer	4.24e-06	9.64e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1B—breast cancer	4.24e-06	9.63e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOA2—breast cancer	4.18e-06	9.51e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA2—breast cancer	4.13e-06	9.4e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX2—breast cancer	4.13e-06	9.4e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NQO1—breast cancer	4.13e-06	9.37e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC2A1—breast cancer	4.13e-06	9.37e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NOS3—breast cancer	4.1e-06	9.31e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX4—breast cancer	4.08e-06	9.28e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SULT1A1—breast cancer	4.08e-06	9.28e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—FASN—breast cancer	4.06e-06	9.22e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BCHE—breast cancer	4.04e-06	9.18e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP3A4—breast cancer	4.02e-06	9.14e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CTNNB1—breast cancer	4e-06	9.1e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC5A5—breast cancer	3.99e-06	9.07e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA1—breast cancer	3.99e-06	9.06e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—IDH1—breast cancer	3.99e-06	9.06e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1B1—breast cancer	3.96e-06	8.99e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NAT2—breast cancer	3.94e-06	8.96e-05	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.93e-06	8.94e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1A—breast cancer	3.91e-06	8.89e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTEN—breast cancer	3.9e-06	8.87e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HSP90AA1—breast cancer	3.88e-06	8.81e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NQO1—breast cancer	3.85e-06	8.76e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC2A1—breast cancer	3.85e-06	8.76e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CB—breast cancer	3.78e-06	8.59e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.77e-06	8.58e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOA1—breast cancer	3.77e-06	8.57e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP3A4—breast cancer	3.76e-06	8.54e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—breast cancer	3.75e-06	8.51e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.74e-06	8.5e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—STK11—breast cancer	3.72e-06	8.45e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP19A1—breast cancer	3.72e-06	8.45e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1B1—breast cancer	3.69e-06	8.4e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.62e-06	8.23e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SRC—breast cancer	3.62e-06	8.22e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOA1—breast cancer	3.52e-06	8.01e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—breast cancer	3.49e-06	7.93e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—STK11—breast cancer	3.47e-06	7.89e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP19A1—breast cancer	3.47e-06	7.89e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MED12—breast cancer	3.46e-06	7.86e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—DPYD—breast cancer	3.46e-06	7.86e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—COMT—breast cancer	3.46e-06	7.86e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—breast cancer	3.44e-06	7.82e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDOA—breast cancer	3.4e-06	7.74e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HMOX1—breast cancer	3.39e-06	7.71e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ITPR1—breast cancer	3.39e-06	7.69e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK3—breast cancer	3.33e-06	7.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOA3—breast cancer	3.31e-06	7.51e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A2—breast cancer	3.28e-06	7.46e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTEN—breast cancer	3.27e-06	7.43e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.26e-06	7.41e-05	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—breast cancer	3.26e-06	7.41e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—breast cancer	3.24e-06	7.37e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TGFB1—breast cancer	3.23e-06	7.35e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—COMT—breast cancer	3.23e-06	7.34e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CPT1A—breast cancer	3.22e-06	7.31e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTR—breast cancer	3.22e-06	7.31e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG2—breast cancer	3.22e-06	7.31e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—breast cancer	3.21e-06	7.3e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TYMS—breast cancer	3.2e-06	7.27e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGFR—breast cancer	3.17e-06	7.21e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HMOX1—breast cancer	3.17e-06	7.2e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ITPR1—breast cancer	3.16e-06	7.19e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—breast cancer	3.16e-06	7.18e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOR1—breast cancer	3.16e-06	7.18e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PLA2G4A—breast cancer	3.16e-06	7.18e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HPGDS—breast cancer	3.15e-06	7.17e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HBA1—breast cancer	3.13e-06	7.12e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ACHE—breast cancer	3.06e-06	6.95e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—breast cancer	3.06e-06	6.95e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—breast cancer	3.04e-06	6.91e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GPX1—breast cancer	3.03e-06	6.88e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1A1—breast cancer	3e-06	6.81e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—breast cancer	3e-06	6.81e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TYMS—breast cancer	2.99e-06	6.79e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ERCC2—breast cancer	2.97e-06	6.76e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOR1—breast cancer	2.95e-06	6.71e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.95e-06	6.71e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—breast cancer	2.95e-06	6.71e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP17A1—breast cancer	2.89e-06	6.58e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ENO1—breast cancer	2.87e-06	6.51e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS1—breast cancer	2.87e-06	6.51e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GPX1—breast cancer	2.83e-06	6.43e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2D6—breast cancer	2.81e-06	6.39e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1A1—breast cancer	2.8e-06	6.36e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—MTHFR—breast cancer	2.79e-06	6.35e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ERCC2—breast cancer	2.78e-06	6.31e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOA2—breast cancer	2.76e-06	6.27e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—breast cancer	2.75e-06	6.25e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—FASN—breast cancer	2.68e-06	6.08e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BCHE—breast cancer	2.66e-06	6.05e-05	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—breast cancer	2.66e-06	6.05e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A5—breast cancer	2.63e-06	5.98e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTHFR—breast cancer	2.61e-06	5.93e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAV1—breast cancer	2.58e-06	5.86e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HRAS—breast cancer	2.55e-06	5.79e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NQO1—breast cancer	2.54e-06	5.78e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC2A1—breast cancer	2.54e-06	5.78e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—breast cancer	2.44e-06	5.54e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1B1—breast cancer	2.44e-06	5.54e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAV1—breast cancer	2.41e-06	5.47e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.39e-06	5.43e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—breast cancer	2.35e-06	5.34e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOA1—breast cancer	2.32e-06	5.28e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—breast cancer	2.31e-06	5.24e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.3e-06	5.23e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP19A1—breast cancer	2.29e-06	5.21e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—STK11—breast cancer	2.29e-06	5.21e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—breast cancer	2.25e-06	5.11e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—breast cancer	2.19e-06	4.98e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—COMT—breast cancer	2.13e-06	4.84e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—breast cancer	2.12e-06	4.82e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HMOX1—breast cancer	2.09e-06	4.75e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ITPR1—breast cancer	2.09e-06	4.74e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CD—breast cancer	2.06e-06	4.69e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—breast cancer	2.04e-06	4.63e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—breast cancer	2.01e-06	4.56e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TYMS—breast cancer	1.97e-06	4.48e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NOS3—breast cancer	1.95e-06	4.43e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOR1—breast cancer	1.95e-06	4.43e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—breast cancer	1.95e-06	4.43e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.95e-06	4.43e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CD—breast cancer	1.93e-06	4.38e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—breast cancer	1.9e-06	4.33e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—breast cancer	1.88e-06	4.28e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GPX1—breast cancer	1.87e-06	4.24e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1A1—breast cancer	1.85e-06	4.2e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ERCC2—breast cancer	1.83e-06	4.16e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NOS3—breast cancer	1.82e-06	4.14e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CB—breast cancer	1.8e-06	4.09e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—breast cancer	1.78e-06	4.05e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTHFR—breast cancer	1.72e-06	3.91e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CB—breast cancer	1.68e-06	3.82e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—breast cancer	1.67e-06	3.78e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAV1—breast cancer	1.59e-06	3.61e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTEN—breast cancer	1.55e-06	3.53e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTEN—breast cancer	1.45e-06	3.3e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—breast cancer	1.45e-06	3.29e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CD—breast cancer	1.27e-06	2.89e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—breast cancer	1.26e-06	2.85e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NOS3—breast cancer	1.2e-06	2.73e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CB—breast cancer	1.11e-06	2.52e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—breast cancer	1.1e-06	2.5e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—breast cancer	1.1e-06	2.49e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—breast cancer	1.02e-06	2.33e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTEN—breast cancer	9.58e-07	2.18e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—breast cancer	8.96e-07	2.04e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—breast cancer	8.37e-07	1.9e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—breast cancer	6.76e-07	1.54e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—breast cancer	5.52e-07	1.25e-05	CbGpPWpGaD
